TACR1 and myeloid leukemia: We recently reported that NK‐1R antagonists promote rapid cytosolic and mitochondrial calcium mobilization in human myeloid leukemia.[12] Therefore, we examined the extent of calcium mobilization upon modulation of NK‐1R activity in human CRC cells.